Could epidurals shield new mothers from postnatal depression?

NCT ID NCT03167905

First seen Aug 06, 2026 · Last updated Aug 07, 2026 · Updated 1 time

Summary

This trial asks whether the type of pain relief a woman receives during labor can influence her risk of developing postnatal depression. About 10-15% of new mothers experience postnatal depression, and this study compares epidural analgesia with non-epidural options like laughing gas or injectable painkillers. Researchers will track mood and persistent pain in healthy women delivering a single baby at term. The goal is to see if one approach better supports emotional well-being after childbirth.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Epidural analgesia (ropivacaine with fentanyl) versus non-epidural options (Entonox, meperidine, remifentanil)
What this could lead to
If epidural pain relief lowers the chance of postnatal depression, it could guide safer, more supportive choices for women during childbirth.
What could go wrong
The trial is in earlier phases and results may not apply to all women. Epidurals carry their own risks, and the link between pain relief and depression is not yet proven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANALGESIA, OBSTETRICAL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • KK Women's and Children's Hospital

    Singapore, 229899, Singapore

More trials for these conditions

Other studies related to the condition(s) this trial covers.